Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seagen Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients must have pathologically confirmed ovarian cancer, which is advanced or recurrent carcinoma, who have failed at least two, but no more than three prior therapies for metastatic disease
Patients must have \> 20% Lewis-y antigen expression documented by immunohistochemistry
LVEF \> 50% by echo or MUGA
Must be platinum resistant as defined by:
* Progression while on initial platinum therapy or
* Progression while on retreatment with initial platinum regimen or
* Relapse \< 6 months after initial therapy
You may not be if
Patients who have had prior therapy with Gemzar®
Cumulative anthracycline exposure \> 300 mg/m2
More than three prior chemotherapy regimens for ovarian cancer (Retreatment with Taxane/Platinum after initial combination is considered only one regimen)
